Upper maxilla myofibroblastic tumour. Initial staging and treatment response evaluation with ¹⁸F-FDG PET/CT

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Nov-Dec;38(6):393-394. doi: 10.1016/j.remn.2019.05.003. Epub 2019 Jun 15.

[Article in English, Spanish]

Authors

I Acevedo Báñez¹, R Fernández López², I Borrego Dorado², L Caballero Gullón², Á de-Bonilla Damiá², J M Jiménez Hoyuela²

Affiliations

¹ U.G.C. de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, España. Electronic address: irene.acevedo.sspa@juntadeandalucia.es.
² U.G.C. de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, España.

PMID: 31208867
DOI: 10.1016/j.remn.2019.05.003

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Female
Fluorodeoxyglucose F18*
Humans
Maxillary Neoplasms / diagnostic imaging*
Maxillary Neoplasms / pathology*
Myofibroblasts
Neoplasm Staging
Positron Emission Tomography Computed Tomography* / methods
Radiopharmaceuticals*
Treatment Outcome

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18